![Ian MacLachlan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian MacLachlan
Corporate Officer/Principal presso New York Academy of Sciences
Posizioni attive di Ian MacLachlan
Società | Posizione | Inizio | Fine |
---|---|---|---|
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Corporate Officer/Principal | - | - |
American Society of Gene Therapy | Corporate Officer/Principal | - | - |
Storia della carriera di Ian MacLachlan
Precedenti posizioni note di Ian MacLachlan
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Direttore Tecnico/Scientifico/R&S | 30/05/2008 | 31/12/2014 |
Protiva Biotherapeutics, Inc.
![]() Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 02/12/2008 |
Fondatore | 01/01/2000 | 02/12/2008 |
Formazione di Ian MacLachlan
University of Alberta | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Canada | 3 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Settori
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Aziende private | 4 |
---|---|
Protiva Biotherapeutics, Inc.
![]() Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
American Society of Gene Therapy | |
Oligonucleotide Therapeutics Society, Inc.
![]() Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
- Borsa valori
- Insiders
- Ian MacLachlan
- Esperienza